Development of the rat model of lapatinib-induced diarrhoea. - Wikidata - wikimedia - TriplyDB

Development of the rat model of lapatinib-induced diarrhoea.

Development of the rat model of lapatinib-induced diarrhoea.

http://www.wikidata.org/entity/Q33999288

about

Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

P2860

Q37071033-61F42FB6-51DB-4C10-A156-3ACBF0E99D9F

P2860

Development of the rat model of lapatinib-induced diarrhoea.

http://www.wikidata.org/entity/Q33999288

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Development of the rat model of lapatinib-induced diarrhoea.

@ast

Development of the rat model of lapatinib-induced diarrhoea.

@en

type

label

Development of the rat model of lapatinib-induced diarrhoea.

@ast

Development of the rat model of lapatinib-induced diarrhoea.

@en

prefLabel

Development of the rat model of lapatinib-induced diarrhoea.

@ast

Development of the rat model of lapatinib-induced diarrhoea.

@en

P1433

Q33999288-08F7EB56-6C54-48E8-97A5-2C4AF2F7CCE9

P1476

Q33999288-2B25B1D8-CE0B-4829-B310-F26F62371564

P2093

Q33999288-49774627-5623-4FB6-B5BD-2B2228BE8911

P2860

Q33999288-00F06245-003F-4251-BE76-6C23B842E4D3

Q33999288-01EA2672-D854-46ED-B25B-9B2C171BDA22

Q33999288-0737FE5D-7981-4EE8-9B76-5D69C0C7BF2E

Q33999288-0F0FC8C4-0D3B-47FB-9D56-78316A2ED926

Q33999288-113C83E0-5C05-4877-9B57-0B440135A43C

Q33999288-18D424E2-D6FD-4DBA-8BCF-210E2763712F

Q33999288-1943FFF9-1957-4F23-94D3-E5818AF3F1D9

Q33999288-2C362505-652D-4FF7-A4CA-0F0E111B09AD

Q33999288-2D79B2AC-A346-4499-B0A0-A2EBF463F7BA

Q33999288-2DC08EBF-75E3-435F-81C8-42788B9415CD

P304

Q33999288-74D5436E-58E2-4E80-AFE5-74C06EECC0F2

P31

Q33999288-E80E8C0D-58C3-4C59-8C47-B3FCE6E9B80D

P356

Q33999288-D38027D6-976A-40B4-AF68-9A5B40963E04

P478

Q33999288-C25F3C5D-D24D-41A1-A325-DEE6E09D44B7

P50

Q33999288-803EB153-9370-4534-BC80-347D0B28E9B0

P577

Q33999288-E6F561A8-3E02-4AF0-8F8F-F83546C1CBD7

P5875

Q33999288-0EDD39F8-67DD-4706-A1B2-12D4A760006A

P698

Q33999288-CC8076D7-F829-43BD-A47B-0E9362CA4E15

P921

Q33999288-4C99A965-F38D-465E-8212-6998D9B93853

P932

Q33999288-629E3B8E-E531-4274-B146-77D419A836F3

P356

P1433

P1476

Development of the rat model of lapatinib-induced diarrhoea

@en

P2093

Joanne M Bowen

http://www.w3.org/2001/XMLSchema#string

P2860

Vandetanib for the treatment of medullary thyroid cancer

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib

Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.

Clinical pharmacokinetics of tyrosine kinase inhibitors.

Managing treatment-related adverse events associated with egfr tyrosine kinase inhibitors in advanced non-small-cell lung cancer.

A phase I and pharmacokinetic study of oral lapatinib administered once or twice daily in patients with solid malignancies.

New approaches to prevent intestinal toxicity of irinotecan-based regimens.

Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.

P304

194185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/194185

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264795682

http://www.w3.org/2001/XMLSchema#string

P698

25126444

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

P932

4121095

http://www.w3.org/2001/XMLSchema#string